147 related articles for article (PubMed ID: 31662968)
61. Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats.
Bolette A; Lecloux G; Rompen E; Albert A; Kerckhofs G; Lambert F
J Craniomaxillofac Surg; 2019 Feb; 47(2):349-356. PubMed ID: 30595476
[TBL] [Abstract][Full Text] [Related]
62. Influence of the cumulative effect of zoledronic acid on periodontal microcirculation in rats.
Kosach GA; Petrosyan AL; Yaremenko AI; Kutukova SI; Zubareva AA; Chefu SG; Vlasov TD
Oral Maxillofac Surg; 2021 Dec; 25(4):487-494. PubMed ID: 33586116
[TBL] [Abstract][Full Text] [Related]
63. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
64. The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats.
Anbinder AL; Prado Fde A; Prado Mde A; Balducci I; Rocha RF
Braz Oral Res; 2007; 21(3):247-52. PubMed ID: 17710291
[TBL] [Abstract][Full Text] [Related]
65. The effects of icariin on wound healing of extraction sites with administration of zoledronic and dexamethasone: A rat model study.
Liu J; Mattheos N; Su C; Deng C; Luo N; Wang Z; Tang H
J Oral Pathol Med; 2018 Feb; 47(2):198-205. PubMed ID: 29130610
[TBL] [Abstract][Full Text] [Related]
66. Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model.
de Molon RS; Cheong S; Bezouglaia O; Dry SM; Pirih F; Cirelli JA; Aghaloo TL; Tetradis S
Bone; 2014 Nov; 68():11-9. PubMed ID: 25093262
[TBL] [Abstract][Full Text] [Related]
67. Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid.
Li JW; Wang JY; Yu RQ; Huo L; Zheng LW
BMC Res Notes; 2022 Jan; 15(1):12. PubMed ID: 35012647
[TBL] [Abstract][Full Text] [Related]
68. Effects of Zoledronic Acid in Experimental Periapical Lesions in Rats: An Imaging and Histological Analysis.
França TRT; Ramos-Perez FMM; Pontual ADA; Castro JFL; Bonan PRF; Perez DEDC
Braz Dent J; 2017; 28(5):566-572. PubMed ID: 29215680
[TBL] [Abstract][Full Text] [Related]
69. Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model.
Tsubouchi Y; Ikeda S; Kataoka M; Tsumura H
J Orthop Surg Res; 2018 Oct; 13(1):267. PubMed ID: 30359257
[TBL] [Abstract][Full Text] [Related]
70. Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment.
Hershman DL; McMahon DJ; Crew KD; Shao T; Cremers S; Brafman L; Awad D; Shane E
J Clin Endocrinol Metab; 2010 Feb; 95(2):559-66. PubMed ID: 20022990
[TBL] [Abstract][Full Text] [Related]
71. Site specific effects of zoledronic acid during tibial and mandibular fracture repair.
Yu YY; Lieu S; Hu D; Miclau T; Colnot C
PLoS One; 2012; 7(2):e31771. PubMed ID: 22359627
[TBL] [Abstract][Full Text] [Related]
72. Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomy.
Xu XC; Chen H; Zhang X; Zhai ZJ; Liu XQ; Qin A; Lu EY
J Transl Med; 2014 Oct; 12():284. PubMed ID: 25269614
[TBL] [Abstract][Full Text] [Related]
73. Outcomes of Zoledronic Acid Use in Paediatric Conditions.
Lim A; Simm PJ; James S; Lee SL; Zacharin M
Horm Res Paediatr; 2020; 93(7-8):442-452. PubMed ID: 33508822
[TBL] [Abstract][Full Text] [Related]
74. Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease.
Soundia A; Hadaya D; Esfandi N; de Molon RS; Bezouglaia O; Dry SM; Pirih FQ; Aghaloo T; Tetradis S
Bone; 2016 Sep; 90():133-41. PubMed ID: 27327410
[TBL] [Abstract][Full Text] [Related]
75. Denosumab vs. zoledronic acid treatment in post-menopausal breast cancer: a 2-year prospective observational study.
Buch-Larsen K; Jørgensen NR; Jensen LT; Andersson M; Schwarz P
Scand J Clin Lab Invest; 2021 Oct; 81(6):425-431. PubMed ID: 34120544
[TBL] [Abstract][Full Text] [Related]
76. Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.
Song M; Alshaikh A; Kim T; Kim S; Dang M; Mehrazarin S; Shin KH; Kang M; Park NH; Kim RH
J Endod; 2016 Nov; 42(11):1641-1646. PubMed ID: 27637460
[TBL] [Abstract][Full Text] [Related]
77. Longitudinal in vivo monitoring of callus remodeling in BMP-7- and Zoledronate-treated fractures.
Mathavan N; Raina DB; Tägil M; Isaksson H
J Orthop Res; 2020 Sep; 38(9):1905-1913. PubMed ID: 32073160
[TBL] [Abstract][Full Text] [Related]
78. Maximizing bone formation in posterior spine fusion using rhBMP-2 and zoledronic acid in wild type and NF1 deficient mice.
Bobyn J; Rasch A; Kathy M; Little DG; Schindeler A
J Orthop Res; 2014 Aug; 32(8):1090-4. PubMed ID: 24719295
[TBL] [Abstract][Full Text] [Related]
79. Improved union and bone strength in a mouse model of NF1 pseudarthrosis treated with recombinant human bone morphogenetic protein-2 and zoledronic acid.
Deo N; Cheng TL; Mikulec K; Peacock L; Little DG; Schindeler A
J Orthop Res; 2018 Mar; 36(3):930-936. PubMed ID: 28767180
[TBL] [Abstract][Full Text] [Related]
80. Local administration of calcitonin inhibits alveolar bone loss in an experimental periodontitis in rats.
Wada-Mihara C; Seto H; Ohba H; Tokunaga K; Kido JI; Nagata T; Naruishi K
Biomed Pharmacother; 2018 Jan; 97():765-770. PubMed ID: 29107933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
